Identification and treatment of T2-low asthma in the era of biologics

Currently, and based on the development of relevant biologic therapies, T2-high is the most well-defined endotype of asthma. Although much progress has been made in elucidating T2-high inflammation pathways, no specific clinically applicable biomarkers for T2-low asthma have been identified. The the...

Full description

Bibliographic Details

Published in:	ERJ open research Vol. 7; no. 2; p. 309
Main Authors:	Kyriakopoulos, Chris, Gogali, Athena, Bartziokas, Konstantinos, Kostikas, Konstantinos
Format:	Journal Article
Language:	English
Published:	England European Respiratory Society 01.04.2021
Subjects:	Reviews
ISSN:	2312-0541, 2312-0541
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!